Gr. Sarantis S.A. (ATH:SAR)
Greece
· Delayed Price · Currency is EUR | Market Cap | 907.74M |
| Revenue (ttm) | 599.56M |
| Net Income (ttm) | 53.06M |
| Shares Out | 63.30M |
| EPS (ttm) | 0.83 |
| PE Ratio | 17.21 |
| Forward PE | 15.87 |
| Dividend | 0.39 (2.71%) |
| Ex-Dividend Date | May 4, 2026 |
| Volume | 22,058 |
| Average Volume | 39,020 |
| Open | 14.50 |
| Previous Close | 14.50 |
| Day's Range | 14.34 - 14.62 |
| 52-Week Range | 12.08 - 15.74 |
| Beta | 0.54 |
| RSI | 44.38 |
| Earnings Date | Sep 8, 2026 |
About Gr. Sarantis
Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and pharmaceutical items in Greece, Portugal, Poland, Romania, Bulgaria, Serbia, Bosnia and Herzegovina, North Macedonia, Slovenia, Croatia, Czech-Slovakia, Hungary, and Ukraine. It operates through Beauty/Skin/Sun Care, Personal Care, Home Care Solutions, Private Label, and Strategic Partnerships segments. The company offers personal and health care products, including food supplements, health and self-care, baby care, body wash, deodorants... [Read more]
Financial Performance
In 2025, Gr. Sarantis's revenue was 599.56 million, a decrease of -0.08% compared to the previous year's 600.06 million. Earnings were 53.06 million, an increase of 15.30%.
Financial StatementsNews
Gr. Sarantis SA (SRTSF) Full Year 2025 Earnings Call Highlights: Strong Profit Growth Amid ...
Gr. Sarantis SA (SRTSF) Full Year 2025 Earnings Call Highlights: Strong Profit Growth Amid Market Challenges
Gr. Sarantis Earnings Call Transcript: H2 2025
Profitability surged in 2025 with EBITDA up 9% and net income up 15.3%, driven by strong beauty and sun care growth and international expansion, despite flat sales. Major CapEx and digital investments set the stage for further margin and cash flow improvements in 2026.
Gr. Sarantis SA (SRTSF) Half Year 2025 Earnings Call Highlights: Strong Growth in Beauty and ...
Gr. Sarantis SA (SRTSF) Half Year 2025 Earnings Call Highlights: Strong Growth in Beauty and Skin Care Amid Market Challenges
Gr. Sarantis Earnings Call Transcript: H1 2025
H1 2025 saw marginal sales growth, but strong double-digit gains in EBITDA, EBIT, and net income, driven by Beauty, Skin Care, and Sun Care. CapEx was revised down, free cash flow and dividends increased, and international expansion—especially in the U.S.—accelerated.
Gr. Sarantis Earnings Call Transcript: H2 2024
Revenue grew 24% year-over-year, with strong EBITDA and net income gains, driven by organic growth and Stella Pack integration. 2025 guidance targets further sales and margin expansion, supported by increased capex and international expansion, especially in skincare and sun care.
Gr. Sarantis SA (SRTSF) (Q2 2024) Earnings Call Transcript Highlights: Strong Growth Across Key ...
Gr. Sarantis SA (SRTSF) (Q2 2024) Earnings Call Transcript Highlights: Strong Growth Across Key Segments
Gr. Sarantis Earnings Call Transcript: H1 2024
Net sales rose over 30% to €302 million, with strong organic growth and margin expansion. Beauty, personal care, and home care segments all delivered double-digit growth, while the Stella Pack acquisition and innovation initiatives further boosted results.